Consolidated Statement of Stockholders' Equity - USD ($)	Total	Common Shares Class A Common Shares	Common Shares Class B Common Shares	Additional Paid in Capital	Accumulated Deficit	Common B Shares
Beginning balance (in shares) at Dec. 31, 2019		50,000	1,111,681			0
Beginning balance at Dec. 31, 2019	$ 12,887,000	$ 0	$ 1,000	$ 92,268,000	$ (79,382,000)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,035,000
Issuance of common stock, net of issuance cost	10,780,000		$ 1,000	10,779,000
Issuance of common stock for restricted stock units (in shares)			37,821
Adjustment for fractional shares in reverse stock splits (in shares)			7,131
Convertible note exchange	2,924,000			2,924,000
Stock-based compensation	2,978,000			2,978,000
Net loss	(24,999,000)				(24,999,000)
Ending balance (in shares) at Dec. 31, 2020		50,000	2,191,633			0
Ending balance at Dec. 31, 2020	4,570,000	$ 0	$ 2,000	108,949,000	(104,381,000)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			6,102,027
Issuance of common stock, net of issuance cost	191,241,000		$ 6,000	191,235,000
Issuance of common stock for restricted stock units (in shares)			878,118
Issuance of common stock for restricted stock units	0		$ 1,000	(1,000)
issuance of common stock in acquisition (in shares)			5,833,333
Issuance of common stock in acquisition	200,959,000		$ 6,000	200,953,000
Treasury stock purchases			(123,089)			123,089
Treasury stock purchases	(4,319,000)					$ (4,319,000)
Issuance of warrant	19,700,000			19,700,000
Stock-based compensation	29,219,000			29,219,000
Net loss	(9,725,000)				(9,725,000)
Ending balance (in shares) at Dec. 31, 2021		50,000	14,882,022			123,089
Ending balance at Dec. 31, 2021	$ 431,645,000	$ 0	$ 15,000	$ 550,055,000	$ (114,106,000)	$ (4,319,000)